Contents

Search


fibrosis

reactive process with proliferation of fibroblasts. Pathology: - c-jun protein is produced in high amounts in end-stage fibrosis of many organs in both mice & humans, including: - idiopathic pulmonary fibrosis - scleroderma - cirrhosis - myelofibrosis [1] - c-jun protein converts cells into pathologic fibroblasts, stimulates fibroblast proliferation, & causes the wayward fibroblasts to produce a molecule that protects them from destruction by macrophages [1] Management: - itraconazole inhibits formtion of fibroblasts causing fibrosis [2]

Specific

angiofibrosis dihydropyrimidine dehydrogenase deficiency; hereditary thymine-uraciluria; familial pyrimidinemia fibroelastosis fibrosing colonopathy hepatic fibrosis mediastinal fibrosis (fibrosing mediastinitis) myelofibrosis myocardial fibrosis myofibrosis plantar fascial fibromatosis; Ledderhose's disease pulmonary fibrosis renal fibrosis retroperitoneal fibrosis (Ormond disease) storiform fibrosis

General

pathologic process sign/symptom

References

  1. Wernig G, Chen SY, Cui L et al. Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci U S A 2017 May 2; 114:4757. PMID: 28424250
  2. Bollong MJ, Yang B, Vergani N et al. Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis. Proc Natl Acad Sci U S A 2017 May 2; 114:4679. PMID: 28416697